CareDx, Inc. is a precision medicine company focused on discovering, developing, and commercializing clinically differentiated, high-value diagnostic solutions for transplant patients. The company’s flagship product, AlloSure, is a non-invasive blood test that measures donor-derived cell-free DNA, providing insights into organ rejection in kidney transplant recipients. CareDx also offers AlloMap, a blood test for heart transplant […]